Neo Ivy Capital Management Buys Shares of 1,203 HCA Healthcare, Inc. (NYSE:HCA)

Neo Ivy Capital Management acquired a new position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 1,203 shares of the company's stock, valued at approximately $361,000.

A number of other hedge funds also recently added to or reduced their stakes in HCA. Whipplewood Advisors LLC purchased a new stake in HCA Healthcare during the 4th quarter valued at $31,000. Tidemark LLC purchased a new stake in HCA Healthcare during the 4th quarter valued at $36,000. Activest Wealth Management increased its stake in shares of HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company's stock worth $40,000 after purchasing an additional 125 shares in the last quarter. Legacy Investment Solutions LLC increased its stake in shares of HCA Healthcare by 99.0% in the 4th quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock worth $62,000 after purchasing an additional 95 shares in the last quarter. Finally, Physician Wealth Advisors Inc. purchased a new stake in shares of HCA Healthcare in the 4th quarter worth $64,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

HCA has been the subject of several analyst reports. Cantor Fitzgerald restated an "overweight" rating and issued a $405.00 price objective on shares of HCA Healthcare in a research note on Monday, January 27th. Bank of America dropped their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a report on Monday, January 27th. Barclays dropped their target price on shares of HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating for the company in a report on Monday, January 27th. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a report on Monday, April 28th. Finally, Royal Bank of Canada dropped their target price on shares of HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating for the company in a report on Monday, April 28th. One analyst has rated the stock with a sell rating, six have assigned a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $381.13.

Insider Activity

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the firm's stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the sale, the chief operating officer now directly owns 12,646 shares in the company, valued at $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.30% of the company's stock.

HCA Healthcare Trading Up 0.6%

HCA Healthcare stock traded up $2.11 during midday trading on Tuesday, reaching $378.70. The stock had a trading volume of 996,914 shares, compared to its average volume of 1,440,094. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The firm has a market cap of $91.11 billion, a price-to-earnings ratio of 17.24, a price-to-earnings-growth ratio of 1.10 and a beta of 1.46. The company has a fifty day moving average of $347.60 and a 200 day moving average of $329.28.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, April 25th. The company reported $6.45 EPS for the quarter, topping analysts' consensus estimates of $5.75 by $0.70. The business had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. The company's quarterly revenue was up 5.7% compared to the same quarter last year. During the same period last year, the company posted $5.36 earnings per share. On average, analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be paid a dividend of $0.72 per share. The ex-dividend date is Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.76%. HCA Healthcare's dividend payout ratio is presently 12.81%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.